novel drug targets
-
Why the Insilico Medicine and Lilly Deal Is One of the Most Significant Moments in Pharmaceutical History
When one of the world’s largest pharmaceutical companies writes a check for $115 million upfront and structures a deal worth up to $2.75 billion in total, the industry pays attention. On March 29, 2026, Insilico Medicine (HKEX: 3696) announced a global R&D collaboration with Eli Lilly and Company that grants Lilly an exclusive worldwide license…